New patent for Boehringer Ingelheim drug TRADJENTA

July 14, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…

The post New patent for Boehringer Ingelheim drug TRADJENTA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.